Difference between revisions of "Daily Positive"
Line 78: | Line 78: | ||
|- valign="top" | |- valign="top" | ||
| | | | ||
− | [[File: | + | [[File:D_EDITORS_PICKS_191.jpg|240px|left|link=https://www.kcl.ac.uk/news/using-the-immune-system-as-a-defence-against-cancer|D+ Editor's Pic]] |
− | <big>''' | + | <big>'''Using the immune system as a defence against cancer'''</big> |
− | <br /> | + | <br />Research published in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence. |
− | + | Several teams, led by Professor Livio Mallucci, from King’s discovered that β-galactoside-binding protein (βGBP), a naturally occurring molecule produced by immune cells can non-specifically target cancer cells, make them undergo cell death and through a stress response pathway make the cancer cells visible to the immune system to prompt an anti-cancer immune response that would secure protection against recurrences. | |
− | + | Major developments in anti-cancer therapies have taken place over the last decade, but as only a subset of patients responds to treatments, there is a need for further development. <small>([https://www.kcl.ac.uk/news/using-the-immune-system-as-a-defence-against-cancer More])</small> | |
<!-- News Edit Guideline Starts | <!-- News Edit Guideline Starts |
Revision as of 01:14, 6 October 2019
|
| ||||||
| |||||||